Fresenius Medical Care AG's latest marketcap:
As of 06/26/2025, Fresenius Medical Care AG's market capitalization has reached $16.2 B. According to our data, Fresenius Medical Care AG is the 1271th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 16.2 B |
| Revenue (ttm) | 21.07 B |
| Net Income (ttm) | 668.15 M |
| Shares Out | 293.41 M |
| EPS (ttm) | 2.28 |
| Forward PE | 12.58 |
| Ex-Dividend Date | 05/23/2025 |
| Earnings Date | 07/29/2025 |
Fresenius Medical Care AG's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | $16.2 B | 22.79% | 1271 |
| 12/31/2024 | $13.29 B | 8.69% | 1337 |
| 12/29/2023 | $12.22 B | 27.48% | 1360 |
| 12/30/2022 | $9.59 B | -49.57% | 1565 |
| 12/31/2021 | $19.01 B | -23.32% | 1049 |
| 12/31/2020 | $24.8 B | 9.7% | 707 |
| 12/31/2019 | $22.6 B | 13.87% | 624 |
| 12/31/2018 | $19.85 B | -38.32% | 582 |
| 12/29/2017 | $32.18 B | 24.87% | 395 |
| 12/30/2016 | $25.77 B | 2.18% | 397 |
Company Profile
About Fresenius Medical Care AG
Fresenius Medical Care AG is a global leader in dialysis and renal care services, operating in Germany, the United States, and internationally. The company specializes in comprehensive treatment solutions for patients with kidney diseases.
Services Offered
- Dialysis Treatment: Outpatient dialysis clinics, hospital-based dialysis services, and acute kidney failure care.
- Patient Support: Clinical monitoring, follow-up assistance, and home delivery of medical supplies.
- Specialty Care: Vascular, cardiovascular, endovascular, and nephrology services.
Product Portfolio
The company develops and manufactures a wide range of healthcare products, including:
- Polysulfone dialyzers and hemodialysis machines
- Peritoneal dialysis cyclers and solutions
- Hemodialysis concentrates and bloodlines
- Renal pharmaceuticals and water treatment systems
- Acute cardiopulmonary and apheresis products
Distribution & Sales
Fresenius Medical Care AG supplies its products to:
- Dialysis clinics and hospitals
- Specialized treatment centers
Sales are conducted through local sales teams, independent distributors, and dealers.
Founded: 1996
Headquarters: Bad Homburg, Germany
Frequently Asked Questions
-
What is Fresenius Medical Care AG's (FMS) current market cap?As of 06/26/2025, Fresenius Medical Care AG (including the parent company, if applicable) has an estimated market capitalization of $16.2 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Fresenius Medical Care AG (FMS) rank globally by market cap?Fresenius Medical Care AG global market capitalization ranking is approximately 1271 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.